PUBLIC COMPANY
save$PRMEPrime Medicine, Inc.
$PRME3.2400-8.47%Cambridge, MA, USupdated 8h ago
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Preclinical1Phase 2
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
Insider activity
source: SEC Form 4routine RSU / option mechanics (4)
- Apr 16, 26grantMakhni Svetlana Ni · Chief Financial Officer800,000 sh
- Feb 26, 26grantReine Allan · Chief Executive Officer1,300,000 sh
- Feb 23, 26grantLEE ANN L. · Chief Technical Officer375,000 sh
- Feb 23, 26grantAlenson Carman · See Remarks140,000 sh
🐶 Hiring Signal
next earnings Nov 6, 2026
Where Prime Medicine, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaOncology 6
News
- STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDBiotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup defections, arbitration, and a U.S.-China rivalry.stat · 23d ago
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that